Literatur
-
1
Empfehlungen der Deutschen Hochdruckliga.
Dtsch Med Wochenschr.
2002;
127 (45)
2364
-
2
Dahlöf. et al .
Cardiovascular morbidity and mortality in the Losartan intervention for endpoint reduction in hypertension study (LIFE).
Lancet.
2002;
359
995
-
3
Lindholm. et al .
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan intervention for endpoint reduction study (LIFE).
Lancet.
2002;
359
1004
-
4
Kjeldsen. et al .
Effects of Losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a losartan intervention for endpoint reduction (LIFE) substudy.
JAMA.
2002;
288
1491
Autor
Prof. Dr. med. Rainer Düsing
Medizinische Universitäts-Poliklinik, Rheinische Friedrich-Wilhelms Universität
Wilhelmstraße 35-37
53111 Bonn
